Supplemental material
Open access
2,544
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain
Carmen Perala Health Economics and Outcomes Research Department, Pfizer S.L.U, Alcobendas (Madrid), SpainCorrespondence[email protected]
View further author information
, View further author information
Fernando Cordidob Endocrinology Department, Complejo Hospitalario Universitario A Coruña, and Universidad de A Coruña, A Coruña, SpainView further author information
, Vicente Gimeno-Ballesterc Pharmacy Department, Hospital Miguel Servet, Zaragoza, SpainView further author information
, Nuria Mird Medical Affairs Department, Pfizer S.L.U, Alcobendas (Madrid), SpainView further author information
, Laura Sánchez-Cenizod Medical Affairs Department, Pfizer S.L.U, Alcobendas (Madrid), SpainView further author information
, Darío Rubio-Rodrígueze Health Value, Madrid, SpainView further author information
& Carlos Rubio-Terrése Health Value, Madrid, SpainView further author information
show all
Pages 105-114
|
Received 05 Feb 2019, Accepted 18 Apr 2019, Published online: 06 May 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.